Granulosa Cell Tumor (Ovary)

Granulosa cell tumor represents the most common ovarian neoplasm affecting mares, accounting for approximately two-thirds to three-quarters of all equine ovarian tumors. This tumor originates from the granulosa cells that normally surround developing follicles within the ovary and are responsible for producing reproductive hormones. While classified as a tumor, granulosa cell tumors are typically benign in nature and rarely metastasize to other organs, making them generally treatable with surgical intervention. However, these tumors can grow to substantial sizes and produce significant hormonal disturbances that profoundly affect the mare's behavior, reproductive function, and overall well-being.

Granulosa cell tumors occur across all horse breeds and can develop in mares of any age, though they are most commonly diagnosed in mares between five and fifteen years of age. The tumor typically affects only one ovary, with the contralateral ovary becoming small and inactive due to hormonal suppression from the tumor. Because these tumors produce hormones in abnormal quantities and ratios, affected mares often display dramatic behavioral changes that frequently prompt veterinary investigation. The economic impact extends beyond treatment costs to include loss of breeding potential during the period of tumor development and the time required for hormonal normalization following surgery.

The impact of granulosa cell tumors on equine health extends well beyond the reproductive system due to their hormone-producing nature. Affected mares commonly exhibit stallion-like behavior including aggression, mounting other horses, territorial behavior, and neck cresting due to elevated testosterone levels. Some mares display persistent estrus behavior, while others show complete anestrus with no cycling activity whatsoever. These behavioral and reproductive abnormalities significantly affect the mare's usefulness for riding, competition, and breeding purposes, creating substantial management challenges for owners and handlers working with affected horses.

The treatability of granulosa cell tumors is generally excellent when properly diagnosed and surgically addressed. Unilateral ovariectomy, the surgical removal of the affected ovary, represents the treatment of choice and typically results in complete resolution of clinical signs. Following surgery, the remaining ovary gradually resumes normal function, and most mares return to normal reproductive cycling within several months to a year. Understanding this condition enables horse owners and breeding managers to recognize the clinical signs early, pursue appropriate diagnostic evaluation, and make informed decisions regarding surgical treatment and the mare's future reproductive potential.

The precise etiology of granulosa cell tumor development in mares remains incompletely understood, though research has identified several factors that may contribute to tumor formation. Granulosa cell tumors arise from the granulosa cells that form the cellular lining of ovarian follicles and normally produce estrogen and other reproductive hormones under the influence of pituitary gonadotropins. The transformation of normal granulosa cells into neoplastic tissue appears to involve disruption of normal cellular regulatory mechanisms, though the specific initiating events remain under investigation. Unlike some cancers with clear genetic or environmental triggers, granulosa cell tumors appear to develop sporadically without obvious predisposing factors in most cases.

Genetic and breed predisposition to granulosa cell tumor development has not been definitively established in horses. The condition occurs across all breeds with no consistently reported increased incidence in any particular breed or bloodline. Some researchers have hypothesized that genetic factors affecting cellular growth regulation or hormone receptor sensitivity might predispose certain individuals to tumor development, but conclusive evidence supporting hereditary transmission remains lacking. The absence of clear familial clustering suggests that if genetic factors play a role, they likely interact with environmental or hormonal influences in complex ways rather than following simple inheritance patterns.

Environmental and management factors have not been convincingly linked to granulosa cell tumor development in mares. Unlike some reproductive conditions affected by nutrition, body condition, or photoperiod manipulation, granulosa cell tumors appear to develop independent of management practices. Mares maintained under vastly different husbandry conditions develop these tumors at similar rates, suggesting that external factors play a minimal role in tumor initiation. However, the hormonal environment within the ovary itself, including local growth factor concentrations and the complex signaling between ovarian cell types, likely influences whether transformed cells progress to form clinically significant tumors.

Risk factors for granulosa cell tumor development are difficult to identify due to the apparently random occurrence of these tumors. Age represents the most notable demographic factor, with most tumors diagnosed in mature mares rather than young horses or aged individuals, though tumors can occur at any age. Reproductive history does not appear to influence tumor development, as both maiden mares and those with extensive breeding histories develop granulosa cell tumors. The lack of identifiable risk factors makes prevention strategies impossible and underscores the importance of recognizing clinical signs for early diagnosis rather than attempting to prevent tumor development.

The pathophysiology of granulosa cell tumors involves progressive enlargement of the affected ovary as neoplastic granulosa cells proliferate and accumulate. These tumors frequently develop cystic areas filled with fluid, sometimes reaching substantial sizes exceeding twenty centimeters in diameter. The tumor cells retain some capacity for hormone production but do so in an unregulated manner, typically producing elevated levels of testosterone, inhibin, and sometimes estrogen or progesterone in abnormal ratios. The elevated inhibin levels suppress pituitary follicle-stimulating hormone release through negative feedback, causing the contralateral ovary to become small and inactive. This hormonal disruption explains the characteristic clinical presentation of behavioral changes, reproductive dysfunction, and physical changes observed in affected mares.

Early warning signs of granulosa cell tumor development in mares are often subtle and may be attributed to normal behavioral variation or training issues before the connection to an ovarian tumor is recognized. Initial changes frequently include mild alterations in the mare's temperament, such as increased irritability, occasional aggressive behavior toward other horses, or subtle changes in responsiveness to handlers. Some mares display early reproductive irregularities including prolonged estrus periods, irregular cycling, or gradual cessation of normal estrous behavior. Because horses are prey animals that naturally minimize overt signs of illness or discomfort, owners must remain attentive to subtle behavioral shifts that might indicate developing health problems including ovarian tumors.

Common symptoms of established granulosa cell tumors reflect the hormonal imbalances produced by these tumors and vary depending on which hormones predominate in each individual case. Stallion-like behavior represents the most frequently recognized clinical sign, occurring in approximately half of affected mares due to elevated testosterone production. This behavior includes aggression toward other horses and handlers, mounting behavior directed at other horses regardless of their reproductive status, territorial marking, squealing, striking, and development of a crested neck similar to that seen in stallions. These behavioral changes can make affected mares dangerous to handle and impossible to use for their intended purposes, often prompting veterinary investigation.

Behavioral changes associated with granulosa cell tumors extend beyond stallion-like displays to include other patterns reflecting hormonal dysfunction. Some mares exhibit persistent estrus behavior, appearing to be constantly in heat with winking, squatting, and receptivity to other horses that continues regardless of season or breeding attempts. Conversely, other affected mares display complete anestrus with no visible cycling behavior whatsoever, appearing reproductively inactive throughout the year. A subset of mares shows unpredictable behavioral fluctuations, alternating between aggressive stallion-like episodes and periods of apparent normalcy or estrus behavior, creating challenging management situations.

Physical signs of granulosa cell tumors include changes in body conformation and condition that develop gradually as the tumor influences hormone levels. Affected mares commonly develop increased muscling and a thickened, crested neck similar to stallion characteristics due to testosterone effects. The external genitalia may enlarge, and some mares develop clitoral hypertrophy noticeable during physical examination. Body condition changes may occur, with some mares becoming more difficult to maintain in appropriate condition. Coat changes including increased coarseness have been reported in some cases. These physical changes, combined with behavioral symptoms, create a distinctive clinical picture suggestive of granulosa cell tumor.

Symptom progression in granulosa cell tumor cases typically occurs gradually over months to years as the tumor enlarges and hormone production increases. Initial subtle behavioral changes often progress to more pronounced stallion-like behavior or complete reproductive dysfunction. The affected ovary continues enlarging, though this internal change is not visible externally and requires veterinary examination for detection. In most cases, the contralateral ovary becomes progressively smaller as hormonal suppression continues. The gradual nature of symptom development means that owners sometimes accommodate behavioral changes incrementally, only recognizing the full extent of the problem when prompted to reflect on changes occurring over extended periods.

Emergency symptoms requiring immediate veterinary attention are uncommon with granulosa cell tumors but can occur in certain circumstances. Large tumors may occasionally twist on their vascular pedicle, causing acute ovarian torsion with severe abdominal pain mimicking colic. Rare cases of tumor rupture can cause internal hemorrhage and acute distress. Though metastasis is extremely rare, any signs of systemic illness, weight loss, or evidence of tumor spread warrant urgent evaluation. Additionally, severely aggressive behavior that develops acutely or escalates rapidly poses safety risks and requires prompt veterinary assessment to determine the cause and appropriate management strategies.

Physical examination of a mare suspected of having a granulosa cell tumor begins with careful evaluation of behavior, body condition, and external physical characteristics. The veterinarian assesses the mare's overall demeanor, noting any stallion-like behavior, aggression, or unusual responses during handling. Physical inspection includes evaluation of neck muscling and cresting, examination of the external genitalia for enlargement or clitoral changes, and assessment of overall body condition and muscling patterns. Transrectal palpation represents a critical component of the physical examination, allowing the veterinarian to assess the size, shape, and consistency of both ovaries. The affected ovary in granulosa cell tumor cases is typically enlarged, sometimes dramatically so, while the contralateral ovary feels small and inactive.

Diagnostic tests for granulosa cell tumor confirmation involve both hormonal analysis and imaging studies that together create a comprehensive picture of ovarian status. Blood hormone analysis typically reveals elevated testosterone levels in affected mares, often substantially above normal female reference ranges. Inhibin levels, when measured, are characteristically elevated and provide strong supportive evidence for the diagnosis. Anti-Mullerian hormone testing has emerged as another useful diagnostic marker, with affected mares showing elevated levels. Progesterone levels are typically low or baseline, reflecting the absence of normal corpus luteum function in most cases. These hormonal patterns, combined with clinical signs and physical findings, usually establish the diagnosis with confidence.

Advanced diagnostic imaging significantly enhances granulosa cell tumor diagnosis and surgical planning. Transrectal ultrasonography represents the most valuable imaging modality, allowing detailed visualization of ovarian structure and size. Granulosa cell tumors typically display a characteristic multicystic or honeycomb appearance on ultrasound, with multiple fluid-filled cavities of varying sizes creating a distinctive pattern. The contralateral ovary appears small and inactive, lacking normal follicular development. Ultrasound examination also enables measurement of tumor dimensions and assessment of associated structures, information valuable for surgical planning. In select cases, additional imaging such as computed tomography may be pursued to fully characterize large tumors or evaluate for potential spread.

Differential diagnosis for granulosa cell tumors includes other conditions causing ovarian enlargement, behavioral changes, or reproductive dysfunction in mares. Ovarian hematomas, which occur following ovulation, can cause temporary ovarian enlargement but typically resolve spontaneously and show different ultrasound characteristics. Other ovarian tumor types, though less common than granulosa cell tumors, must be considered and may show different imaging patterns or hormonal profiles. Behavioral changes alone might result from pain, training issues, or other medical conditions rather than ovarian tumors. Anovulatory follicles can cause ovarian enlargement but lack the multicystic appearance and hormonal changes characteristic of granulosa cell tumors. The combination of characteristic clinical signs, hormonal patterns, and ultrasonographic appearance typically allows confident differentiation of granulosa cell tumors from these alternative diagnoses.

Emergency and immediate treatment for granulosa cell tumors is generally not required unless complications such as ovarian torsion or rupture occur. Unlike conditions such as colic or laminitis that demand immediate intervention, granulosa cell tumors typically allow time for thorough diagnostic workup and careful surgical planning. However, if acute complications occur, emergency stabilization including pain management, intravenous fluid support, and potentially emergency surgery may be necessary. For uncomplicated cases, the priority involves completing diagnostic evaluation, discussing treatment options with the owner, and scheduling surgical intervention at an appropriate time with adequate preparation for both the mare and the surgical team.

Medical management alone does not effectively treat granulosa cell tumors, as no medications reliably cause tumor regression or long-term symptom resolution. Some practitioners have attempted hormonal therapies to manage behavioral symptoms while awaiting surgery or in cases where surgery is declined, but these approaches provide inconsistent results and do not address the underlying tumor. Deslorelin implants or other hormonal manipulations may temporarily modify behavior in some mares but do not represent definitive treatment. The hormone-producing nature of these tumors means that symptoms typically persist or worsen as long as the tumor remains, making surgical removal the only reliable treatment approach.

Surgical removal of the affected ovary, termed unilateral ovariectomy, represents the definitive treatment for granulosa cell tumors and provides excellent outcomes in most cases. Several surgical approaches exist, with selection depending on tumor size, surgeon preference, and available facilities. Standing flank ovariectomy performed under sedation and local anesthesia works well for smaller tumors and offers advantages including reduced anesthetic risk and faster recovery. Laparoscopic approaches provide minimally invasive options with excellent visualization. For very large tumors, ventral midline celiotomy under general anesthesia may be necessary to safely remove the mass. Regardless of approach, complete removal of the affected ovary resolves the hormonal imbalances driving clinical signs.

Supportive care during the treatment period focuses on managing the mare safely given her behavioral abnormalities and preparing her for surgery. Housing and handling adjustments may be necessary to ensure safety for both the mare and handlers, potentially including isolated turnout and careful approaches during daily care. Nutritional support ensures the mare enters surgery in appropriate condition. Pre-surgical evaluation including bloodwork confirms the mare is a suitable anesthetic candidate. Post-operatively, supportive care includes appropriate pain management, monitoring for surgical complications, and gradual return to normal activity as healing progresses.

Rehabilitation and return to work following ovariectomy for granulosa cell tumor involves both physical recovery from surgery and the gradual hormonal normalization that determines when the mare returns to normal behavior and reproductive function. Physical recovery from surgery typically progresses rapidly, with most mares returning to light work within several weeks depending on the surgical approach used. Hormonal normalization occurs more slowly, as the suppressed contralateral ovary gradually resumes function. Behavioral improvements often begin within weeks of surgery as testosterone levels decline, though complete normalization may require several months. Return to reproductive cycling typically occurs within four to twelve months, with most mares eventually capable of normal breeding if desired.

Treatment decision factors for granulosa cell tumor cases include the mare's intended use, age, value, owner preferences, and surgical feasibility given tumor size and available facilities. For breeding mares, surgery offers the opportunity to restore fertility, making it strongly indicated in most cases. For mares used primarily for riding or competition, surgery eliminates behavioral problems interfering with performance and safety. Cost considerations, including surgery expenses and time away from use, factor into decision-making for some owners. Tumor size influences surgical approach selection and associated costs. Overall, the excellent prognosis following surgery and the progressive nature of untreated tumors generally favor surgical intervention for most affected mares.

Recovery timeline following ovariectomy for granulosa cell tumor encompasses both surgical healing and the hormonal normalization that ultimately determines return to normal function. Surgical site healing typically progresses straightforwardly over two to four weeks depending on the surgical approach used, with standing flank procedures generally allowing faster return to activity than ventral midline approaches. During this initial period, the mare requires restricted activity, surgical site monitoring, and any prescribed medications including antibiotics and anti-inflammatory agents. Most mares tolerate the surgical recovery period well and return to turnout and light exercise within several weeks of surgery.

Post-treatment care and monitoring focus on ensuring complete surgical healing and tracking the expected hormonal changes following tumor removal. Surgical site inspection identifies any complications such as infection or dehiscence that require intervention. Follow-up examinations, including repeat transrectal palpation and ultrasonography, confirm absence of tumor remnants and monitor the contralateral ovary for resumed development. Serial hormone measurements, particularly testosterone and inhibin levels, document the expected decline following tumor removal. Behavioral monitoring tracks improvements that typically begin within weeks as abnormal hormone levels normalize. Owners should maintain communication with their veterinarian regarding recovery progress and any concerns that arise.

Prognosis following surgical treatment for granulosa cell tumor is generally excellent for both behavioral normalization and return to fertility. The vast majority of mares show marked behavioral improvement within weeks to months of surgery as testosterone levels decline. Return to normal estrous cycling occurs in approximately seventy to ninety percent of mares, though the timeframe varies from several months to over a year in some cases. Mares that recover normal cycling typically demonstrate normal fertility and can successfully conceive and carry pregnancies. Factors influencing prognosis include tumor duration prior to diagnosis, mare age, and the health of the contralateral ovary, though most mares recover satisfactorily regardless of these factors.

Long-term soundness and function outlook for mares following granulosa cell tumor treatment is favorable in most cases. Behavioral changes typically resolve completely, allowing the mare to return to her previous use whether for breeding, riding, or competition. Reproductive function returns in most mares, enabling successful breeding careers following recovery. Recurrence of granulosa cell tumors is rare following complete surgical removal, and development of tumors in the remaining ovary occurs infrequently. Mares that do not return to normal cycling despite appropriate recovery time may have underlying ovarian dysfunction unrelated to the tumor. Overall, the excellent prognosis following treatment makes surgical intervention a worthwhile investment for most affected mares.

Management practices for preventing granulosa cell tumors are essentially nonexistent because no controllable factors have been identified that influence tumor development. Unlike conditions prevented through specific husbandry modifications, granulosa cell tumors appear to arise spontaneously without clear environmental, nutritional, or management triggers. Good general reproductive management including regular veterinary examinations during breeding seasons may facilitate early tumor detection but does not prevent tumor formation. The focus of management should therefore emphasize recognition of clinical signs and prompt diagnostic evaluation rather than prevention strategies.

Nutritional prevention strategies do not exist for granulosa cell tumors, as no dietary factors have been linked to tumor development or protection. Maintaining appropriate body condition and providing balanced nutrition supports overall mare health but has no demonstrated effect on granulosa cell tumor occurrence. Unlike some metabolic conditions where dietary management plays a central role in prevention, reproductive tumors like granulosa cell tumors develop independent of nutritional influences. Horse owners should continue providing appropriate nutrition for their mares' life stages and activity levels without expecting this to influence ovarian tumor risk.

Exercise and conditioning programs do not influence granulosa cell tumor development, and no modifications to exercise protocols are indicated for prevention purposes. Mares in various levels of work from pasture companions to high-level competition horses develop these tumors at similar rates, indicating that activity level does not protect against or predispose to tumor formation. Maintaining appropriate fitness supports overall health and may facilitate surgical recovery if treatment becomes necessary but does not prevent tumor occurrence.

Environmental factors including housing type, turnout access, herd composition, and geographic location have not been associated with granulosa cell tumor development. Mares maintained under diverse conditions develop these tumors without clear environmental patterns. Unlike infectious or parasitic conditions where environmental management can reduce disease risk, neoplastic conditions like granulosa cell tumors arise from internal cellular changes not influenced by external environmental factors. Owners should manage their mares' environments based on general health and welfare considerations without expecting environmental modifications to affect tumor risk.

Vaccination and deworming protocols have no relationship to granulosa cell tumor development, as these tumors are neoplastic rather than infectious or parasitic in origin. Maintaining appropriate preventive care programs supports overall health but does not influence ovarian tumor risk. The most effective approach to granulosa cell tumors emphasizes owner and manager education regarding clinical signs, enabling early recognition and prompt veterinary evaluation when behavioral or reproductive changes occur. Regular reproductive examinations during breeding season or annual wellness visits may identify ovarian abnormalities before dramatic clinical signs develop, potentially allowing earlier intervention.

Daily management adjustments for mares diagnosed with granulosa cell tumors focus primarily on safety considerations given the behavioral changes commonly associated with these tumors. Stallion-like behavior including aggression, mounting, and unpredictability requires modified handling approaches to protect both handlers and other horses. Affected mares may need to be handled by experienced personnel aware of the potential for aggressive or unexpected behavior. Leading with adequate restraint, maintaining appropriate distance, and approaching cautiously become necessary when managing affected mares. Daily observation should note behavioral patterns, intensity of symptoms, and any changes that might indicate tumor progression or complications.

Housing and turnout considerations for mares with granulosa cell tumors must balance the mare's welfare needs with safety concerns arising from behavioral abnormalities. Severely affected mares may require individual turnout to prevent injury to other horses from mounting or aggressive behavior. Fencing must be adequate to contain a mare displaying stallion-like territorial behavior, as some affected mares become fence challengers. Stall housing should provide adequate space and sturdy construction. Herd dynamics can be significantly disrupted by an affected mare's behavior, potentially requiring permanent removal from group housing situations until surgical treatment resolves the hormonal imbalances.

Exercise modifications for mares with granulosa cell tumors depend on the severity of behavioral changes and the mare's safety during handling and riding. Mildly affected mares may continue normal work with appropriate caution, while severely affected mares may be unsafe to ride or handle for training purposes. Some mares become difficult to tack and mount due to aggressive behavior or sensitivity. Ground work and riding should only continue if both horse and handler safety can be maintained. The temporary nature of these limitations, assuming surgical treatment is pursued, means that exercise restrictions represent a short-term management adjustment rather than a permanent change.

Monitoring and ongoing care for mares with granulosa cell tumors involves tracking behavioral patterns, noting any changes in symptom severity, and maintaining communication with the veterinary team. Owners should document behavioral episodes including frequency, triggers if identifiable, and intensity to help guide treatment timing and assess response following surgery. Weight and body condition monitoring ensures the mare maintains appropriate condition through diagnosis and treatment. Any signs suggesting acute complications such as severe abdominal pain warrant immediate veterinary contact. Regular communication with the veterinarian ensures timely surgical scheduling and addresses any concerns arising during the management period.

Quality of life and use considerations for mares with granulosa cell tumors involve evaluating current welfare and making decisions about treatment timing and approach. Mares with mild symptoms may maintain acceptable quality of life while awaiting surgery, continuing limited use if safely possible. Severely affected mares may experience significant welfare compromise from their own behavior, including inability to socialize normally with other horses and stress from dramatic hormonal fluctuations. Use limitations affect the mare's role, whether as breeding animal, riding horse, or companion. These considerations generally support timely surgical intervention to restore normal behavior and quality of life. The excellent prognosis following surgery makes treatment strongly indicated for most affected mares, with timing influenced by practical factors including facility availability and mare condition.

High-risk breed identification for granulosa cell tumors is not possible because no clear breed predisposition has been established for this condition. Granulosa cell tumors occur across all horse breeds including Thoroughbreds, Warmbloods, Quarter Horses, Arabians, draft breeds, ponies, and mixed-breed horses. Studies examining tumor occurrence have not identified statistically significant differences in incidence among breeds. The apparent equal-opportunity nature of this tumor suggests that breed-specific genetic factors do not play a major role in tumor development. Owners of all breeds should remain vigilant for clinical signs regardless of their horses' breeding.

Use and discipline considerations do not significantly influence granulosa cell tumor occurrence, though the impact of tumors may vary based on the mare's intended use. Sport horse mares experiencing stallion-like behavior become unsafe for competition and training, creating significant impact on their careers. Breeding mares face fertility implications until surgical treatment restores normal reproductive function. Pleasure and companion horses may tolerate mild behavioral changes better than high-level performance horses, though significant symptoms affect quality of life regardless of use. All mares demonstrating behavioral changes, reproductive abnormalities, or physical changes suggesting granulosa cell tumor deserve diagnostic evaluation regardless of breed or use.

Genetic testing and breeding recommendations for granulosa cell tumors are limited by the absence of identified genetic factors contributing to tumor development. No genetic tests exist to predict granulosa cell tumor risk, and no breeding recommendations can be made to reduce tumor occurrence in offspring. Affected mares are not typically excluded from breeding programs following successful surgical treatment, as no hereditary component has been established. The sporadic nature of tumor occurrence means that neither affected mares nor their relatives require special breeding considerations. Research continues to explore potential genetic contributions to ovarian tumor development, but current evidence does not support genetic screening or selective breeding strategies for prevention.

Commonly co-occurring conditions with granulosa cell tumors are relatively limited because these tumors typically develop as isolated abnormalities rather than as part of broader disease syndromes. However, affected mares may develop secondary conditions related to their behavioral changes, including injuries from aggressive interactions with other horses or handlers. The physical changes induced by elevated testosterone, such as increased muscling, do not typically cause additional health problems. Ovarian inactivity in the contralateral ovary represents a consistent finding but resolves following tumor removal rather than persisting as an ongoing condition. Overall, granulosa cell tumors tend to occur as isolated problems without significant associations with other disease processes.

Conditions with similar symptoms to granulosa cell tumors include other causes of behavioral changes, reproductive dysfunction, or ovarian abnormalities in mares. Other ovarian tumor types, though less common, can produce overlapping clinical signs. Ovarian hematomas cause ovarian enlargement and may affect cycling but typically resolve spontaneously. Anovulatory follicles can persist and cause ovarian enlargement without the characteristic ultrasound appearance of granulosa cell tumors. Cushing's disease and other endocrine disorders can cause behavioral changes and reproductive dysfunction, though the specific patterns differ from granulosa cell tumors. Behavioral issues unrelated to medical conditions, including training problems or pain from other sources, must also be considered when evaluating mares with temperament changes.

Potential complications from granulosa cell tumors are uncommon but can include serious acute problems in rare cases. Ovarian torsion, where the enlarged ovary twists on its vascular pedicle, causes acute severe abdominal pain requiring emergency intervention. Tumor rupture can cause internal hemorrhage, though this occurs rarely. Extremely large tumors may cause physical discomfort or interfere with other abdominal organs. Metastasis of granulosa cell tumors is rare but has been reported in isolated cases, typically involving spread to the contralateral ovary, peritoneum, or occasionally more distant sites. The most common complication is simply continued tumor growth and progressive symptom development if surgical treatment is delayed, underscoring the value of timely intervention once diagnosis is established.